Gsk Share Discussion Threads

[philanderer] 10/9/2019 17:45

'Pharmaceutical companies 'should publicly disclose payments to doctors', experts say'


Although the payments are legal, experts say the lack of transparency is eroding public trust in healthcare in the UK.

[iknowverylittle] 10/9/2019 14:38

50p down in one day not bad, but had worse, or better in this case

[iknowverylittle] 10/9/2019 14:38

Maybe tomorrow sub 16?

[gbh2] 10/9/2019 14:29

I'll have some more at 1600, just a case of freeing up cash as the market rises on over holdings.

[spud] 10/9/2019 14:12

Tucked away another 1k shares.

spud

[crossing_the_rubicon] 10/9/2019 13:24

A Sub £16 buyer as well Iknow, if am lucky for it to come that low.

[iknowverylittle] 10/9/2019 13:04

I'm hoping for a sub £16 buy in!

[gbh2] 10/9/2019 13:01

Picked up a few, it's recovered from this level several times before so in for a penny....or so.

[iknowverylittle] 10/9/2019 12:18

Think I mite have to buy back in at this rate ?

[spacecake] 10/9/2019 11:38

American lawmakers plan a legislative crackdown on runaway prescription drug prices in the US.

But the soon to be announced completion of the consumer healthcare merger should be unaffected, over the counter consumer products unaffected in the US?

[gbh2] 10/9/2019 11:05

Thank you sogo't, time to find some cash :)

[xxxxxy] 10/9/2019 11:03

But price hasn't changed much years. Decades

[xxxxxy] 10/9/2019 11:01

Not buying anything anywhere at the moment. Waiting until they sub 15.30ish

[sogoesit] 10/9/2019 10:52

Yes, thereabouts, gbh:

[gbh2] 10/9/2019 10:46

Lost track of these but now looking interesting, is the annual divi still 80p?

[crossing_the_rubicon] 10/9/2019 10:35

Been a long time coming these price curbs though Plat.

[abdullla] 10/9/2019 09:57

But the Divi is still there.

[lovewinshatelosses] 10/9/2019 08:55

Is that the reason for the fairly big drop yesterday and today so far do you think? Just when you think GSK is onto a decent upward trend... :)

[philanderer] 10/9/2019 00:09

Market report: Big Pharma hit as US plans price curbs


Healthcare stocks were the worst performers on the FTSE 100 on Monday, as pharmaceutical giants AstraZeneca and GlaxoSmithKline both suffered following reports that American lawmakers plan a legislative crackdown on runaway prescription drug prices in the US.

In a rare display of co-operation, Donald Trump’s White House and politicians in the Democrat-controlled House of Congress are both tackling the issue, in which companies ramp up prices of essential medicine.

The Washington Post reported that Nancy Pelosi, house speaker, is preparing to unveil drug pricing legislation “as early as this week” – setting the stage for an intense period of drafting before the political agenda is overwhelmed.

[spud] 09/9/2019 15:31

Snaffled another 1k shares. I strongly believe that this has great growth prospects.

spud

[spud] 09/9/2019 15:12

That'll suit me! (but probably not many others).

spud

[tialouise] 09/9/2019 14:23

Could test 1650 easily !

[thamestrader] 09/9/2019 12:48

Yep, i’m back in too. Only up to my toes, mind.

[spud] 09/9/2019 12:12

Taken another 1k shares on the dip.

spud

[tradermichael] 09/9/2019 12:08

£1 = USD 1.24